Local injection of GluN2B-containing NMDAR antagonists or the specific GluN2B antagonist rislenemdaz into the LHb has been demonstrated to improve alcohol-induced anxiety-like behaviors (139) and CRS-induced despair-like behaviors (140). This evidence concerns the gene GRIN2B and congenital rubella syndrome.